Paper Details
- Home
- Paper Details
An Overview of Medullary Thyroid Cancer Cases Treated at Kuwait Cancer Control Center.
Author: AlSalehKhaled, BedairAhmed, ElSherifyMustafa, HusseinAmany, MohantyAsit, NazeehMarwa, SafwatReham, SheteJitendra
Original Abstract of the Article :
Medullary thyroid cancers (MTC) constitute about 5% of all thyroid cancers. The 10-year overall survival (OS) rate of patients with localized disease in thyroid for this pathology is 80% to 90% which is comparable with differentiated thyroid cancers, figures drop to 75% for cases with nodal metastas...See full text at original site
Dr.Camel's Paper Summary Blogラクダ博士について
ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。
* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。
引用元:
https://pubmed.ncbi.nlm.nih.gov/33431361
データ提供:米国国立医学図書館(NLM)
Combating Medullary Thyroid Cancer: A Multi-faceted Approach
Medullary thyroid cancer (MTC) is a type of thyroid cancer that accounts for a significant portion of all thyroid cancers. This study delves into the challenges of treating MTC, exploring the various treatment options and the importance of multidisciplinary care. The study highlights the importance of surgery as the cornerstone of MTC treatment, emphasizing the role of total thyroidectomy and nodal dissection. It also explores the use of adjuvant therapies such as radiotherapy and the emerging role of targeted therapies like vandetanib and cabozantinib. These targeted therapies offer a new hope for patients with metastatic MTC, providing a more precise and effective way to combat the disease.Targeting the Enemy: Personalized Treatment for MTC
This study emphasizes the need for personalized treatment strategies for MTC, acknowledging the variability in disease progression and the need to tailor treatment plans to the individual patient. This highlights the importance of a multidisciplinary approach, involving oncologists, surgeons, and other specialists, to ensure optimal care and improve patient outcomes.Navigating the Sands of Treatment: Staying Vigilant
The study underscores the challenges associated with long-term management of MTC, particularly with the use of targeted therapies. It emphasizes the need for careful monitoring of side effects and dose adjustments to ensure the benefits of these therapies outweigh the risks. This highlights the importance of ongoing communication between patients and healthcare providers for optimal treatment and management of the disease.Dr.Camel's Conclusion
Just as a desert traveler needs to navigate treacherous terrain, patients with MTC need to navigate a complex landscape of treatment options. This study highlights the importance of a multidisciplinary approach and personalized care, emphasizing that finding the right path through this journey is crucial for successful treatment and management of the disease.Date :
- Date Completed 2021-08-20
- Date Revised 2021-08-20
Related Literature
SNS
PICO Info
in preparation
Languages
English
Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.